Progressive Biofunctional Nanoplatforms for Treatment of vital NonCommunicable Diseases: A critical review
International Journal of Drug Delivery Technology · 25.04.2026 · 16 (20s)
DOI: 10.25258/ijddt.16.20s.76 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.04.2026. Verfasst von Trisha Dutta und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Noncommunicable diseases (NCDs), together with cancer, cardiovascular illnesses, diabetes, and chronic respiratory diseases, continue to be the biggest contributors to morbidity and mortality worldwide. The drawbacks of conventional medicines, such as low bioavailability, systemic toxicity, and ineffective targeted administration, have paved the path for the blooming of bioactive nanomaterials. Nanomaterials are now broadly utilized in the medical and health industries as an innovative treatment for various diseases, primarily NCDs, caused by rapid advancements in nanotechnology. These advanced materials offer distinct advantages, including precise targeting, controlled dispensing, and enhanced therapeutic efficacy. Bioactive nanomaterials (BNMs) use chemical and mechanical characteristics such as crystal structure, charge on the surface, functional groups on the surface, arrangement, and size to generate biological activity and treat illnesses. Unlike traditional nanometer pharmaceutical composing, BNMs do not rely on drug delivery and are anticipated to offer improved therapeutic outcomes. This study reviews the recent advancements, mechanisms, a thorough introduction to the usual biomedical applications involving bioactive nanoparticles and therapeutic prospects of futuristic bioactive nanoparticles in the treatment of major NCDs, as well as the accompanying challenges, technical hurdles and significant scientific issues confronting bioactive nanoparticles in disease diagnosis and therapy and forthcoming developments.
Zitieren
APA
Dutta, T., Hazarika, S., Baruah, S., Phangchopi, N., Phukan, S., Lahkar, L., Chetia, J., Dutta, M. P., & Saikia, M. (2026). Progressive Biofunctional Nanoplatforms for Treatment of vital NonCommunicable Diseases: A critical review. International Journal of Drug Delivery Technology, 16(20s). https://doi.org/10.25258/ijddt.16.20s.76
Vancouver
Dutta T, Hazarika S, Baruah S, Phangchopi N, Phukan S, Lahkar L, et al. Progressive Biofunctional Nanoplatforms for Treatment of vital NonCommunicable Diseases: A critical review. International Journal of Drug Delivery Technology. 2026;16(20s). doi:10.25258/ijddt.16.20s.76
BibTeX
@article{Dutta2026,
author = {Dutta, Trisha and Hazarika, Sangeeta and Baruah, Sukanya and Phangchopi, Navina and Phukan, Shreemoyee and Lahkar, Lipika and Chetia, Junali and Dutta, Manash Pratim and Saikia, Monmi},
title = {Progressive Biofunctional Nanoplatforms for Treatment of vital NonCommunicable Diseases: A critical review},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {20s},
doi = {10.25258/ijddt.16.20s.76}
}
EUVIMED